ASRT

Assertio Holdings Inc

Mar 19 • 04:00PM ET

13.72

+0.04 0.29 %

Healthcare • Drug Manufacturers - Specialty & Generic • USA • NASD

Peers: SFM OIS DCTH HRTX PBPB MYE OPI NUS FET TSE

Index	-	P/E	-	EPS (ttm)	-4.92	Insider Own	2.65%	Shs Outstand	6.42M	Perf Week	18.07%
Market Cap	88.43M	Forward P/E	6.95	EPS next Y	1.97	Insider Trans	-4.98%	Shs Float	6.27M	Perf Month	15.59%
Enterprise Value	65.27M	PEG	-	EPS next Q	-1.85	Inst Own	32.27%	Short Float	4.07%	Perf Quarter	24.72%
Income	-30.38M	P/S	0.74	EPS this Y	96.36%	Inst Trans	5.70%	Short Ratio	4.49	Perf Half Y	-3.36%
Sales	118.71M	P/B	0.94	EPS next Y	1243.96%	ROA	-11.01%	Short Interest	0.26M	Perf YTD	51.27%
Book/sh	14.63	P/C	1.39	EPS next 5Y	-	ROE	-28.25%	52W High	15.15 -9.44%	Perf Year	28.84%
Cash/sh	9.84	P/FCF	-	EPS past 3/5Y	- 21.69%	ROIC	-22.67%	52W Low	7.71 78.05%	Perf 3Y	-84.31%
Dividend Est.	-	EV/EBITDA	5.11	Sales past 3/5Y	-8.75% 2.24%	Gross Margin	44.92%	Volatility	7.72% 4.83%	Perf 5Y	-75.41%
Dividend TTM	-	EV/Sales	0.55	EPS Y/Y TTM	-39.97%	Oper. Margin	-14.51%	ATR (14)	0.65	Perf 10Y	-98.28%
Dividend Ex-Date	-	Quick Ratio	1.51	Sales Y/Y TTM	-5.00%	Profit Margin	-25.59%	RSI (14)	72.93	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.70	EPS Q/Q	-12.91%	SMA20	14.22%	Beta	0.71	Target Price	38.25
Payout	-	Debt/Eq	0.43	Sales Q/Q	-57.92%	SMA50	17.61%	Rel Volume	1.42	Prev Close	13.68
Employees	53	LT Debt/Eq	0.43	Earnings	Mar 16 AMC	SMA200	19.92%	Avg Volume	56.81K	Price	13.72
IPO	Dec 02, 1997	Option/Short	Yes / Yes	EPS/Sales Surpr.	40.43% 118.45%	Trades		Volume	80,490	Change	0.29%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-26-24	Initiated	Maxim Group	Buy	$3
Jul-03-24	Initiated	H.C. Wainwright	Buy	$4
Nov-07-22	Initiated	Lake Street	Buy	$7
Nov-30-18	Downgrade	Mizuho	Buy → Neutral

Mar-16-26 11:00PM	Assertio Holdings Inc (ASRT) Q4 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) +6.20%
08:13PM	Assertio Holdings, Inc. Q4 2025 Earnings Call Summary (Moby)
04:30PM	Assertio: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Assertio Reports Fourth Quarter and Full Year 2025 Financial Results (Business Wire)
Mar-05-26 12:37PM	Immunovant Stock Surges 17% in 3 Months: What's Driving It? (Zacks)
08:24AM	Loading…
08:24AM	AMRN Stock Soars 37.7% in a Year: Here's What You Need to Know (Zacks)
Mar-04-26 09:40AM	Is Assertio (ASRT) Outperforming Other Medical Stocks This Year? (Zacks)
Mar-03-26 04:30PM	Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 16, 2026 (Business Wire)
Mar-02-26 09:10AM	REGN & SNY's Dupixent Gets CHMP Nod for Pediatric Use in Urticaria (Zacks)
Feb-27-26 12:35PM	PBYI Q4 Earnings & Sales Beat Estimates, Stock Down on Weak 2026 View (Zacks)
12:06PM	PRGO Q4 Earnings Miss, Sales Beat, Stock Down on Weak 2026 View (Zacks)
07:44AM	Lipocine (LPCN) Soars 5.5%: Is Further Upside Left in the Stock? (Zacks)
Feb-26-26 09:21AM	Amarin's Q4 Earnings Beat Estimates, Stock Down as Revenues Miss (Zacks)
09:02AM	UTHR Tops Q4 Earnings Estimates, Shares Surge 13% on Strong Guidance (Zacks)
Feb-25-26 11:03AM	BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y (Zacks)
11:01AM	Loading…
11:01AM	IOVA Beats on Q4 Earnings & Sales, Stock Soars on Pipeline Progress (Zacks)
Feb-24-26 11:31AM	SMMT Incurs Wider-Than-Expected Q4 Loss, Pipeline Progress in Focus (Zacks)
Feb-23-26 10:47AM	FDA Accepts Roche's NDA Seeking Approval for Breast Cancer Drug (Zacks)
Feb-16-26 09:40AM	Are Medical Stocks Lagging Assertio (ASRT) This Year? (Zacks)
Feb-12-26 08:10AM	Zoetis (ZTS) Beats Q4 Earnings and Revenue Estimates (Zacks)
Feb-10-26 10:43AM	SNY's Rare Disease Drug Wins FDA Breakthrough and Japan Orphan Status (Zacks)
Feb-06-26 11:31AM	KOD Stock Up 24% in 3 Months: Here's What You Need to Know (Zacks) +9.64%
Feb-05-26 11:42AM	Verastem Stock Rises Nearly 8% on Strong Q4 & 2025 Preliminary Results (Zacks)
Feb-04-26 10:11AM	FDA Rejects AZN's Saphnelo SubQ Formulation, Priority Tag to Datroway (Zacks)
Feb-03-26 11:59AM	Sanofi's Venglustat Meets Primary Endpoints in Gaucher Disease Study (Zacks)
06:28AM	Strength Seen in Harrow (HROW): Can Its 9.7% Jump Turn into More Strength? (Zacks)
Feb-02-26 11:03AM	Ultragenyx Pharmaceutical Resubmits UX111 BLA for Sanfilippo Syndrome (Zacks)
09:55AM	Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High? (Zacks)
Jan-30-26 10:24AM	FDA Accepts SMMT's Application Seeking Approval for NSCLC Drug (Zacks)
09:40AM	Has ADC Therapeutics (ADCT) Outpaced Other Medical Stocks This Year? (Zacks)
09:55AM	Loading…
Jan-16-26 09:55AM	Wall Street Analysts Think Assertio (ASRT) Could Surge 249.87%: Read This Before Placing a Bet (Zacks)
Jan-14-26 09:40AM	Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? (Zacks)
Jan-12-26 04:15PM	Assertio Holdings, Inc. Regains Compliance With Nasdaq Listing Requirements (Business Wire) +10.89%
Jan-09-26 01:45PM	Assertio Announces Publication of Rolvedon Same-Day Dosing Clinical Trial (Business Wire)
Dec-22-25 04:30PM	Assertio Holdings, Inc. Announces 1-for-15 Reverse Stock Split (Business Wire) -9.81%
Nov-11-25 04:01AM	Assertio Holdings Inc (ASRT) Q3 2025 Earnings Call Highlights: Impressive Growth Amid Market ... (GuruFocus.com) +14.89%
Nov-10-25 05:45PM	Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates (Zacks) +5.33%
04:41PM	Assertio: Q3 Earnings Snapshot (Associated Press Finance)
04:13PM	Assertio Reports Third Quarter 2025 Financial Results (Business Wire)
Nov-06-25 08:30AM	Xeris Biopharma (XERS) Reports Break-Even Earnings for Q3 (Zacks)
Oct-28-25 09:15AM	Assertio Announces Leadership Transition (GlobeNewswire)
Sep-23-25 05:04AM	New Strong Sell Stocks for September 23rd (Zacks)
Sep-19-25 06:23AM	New Strong Sell Stocks for September 19th (Zacks) -7.22%
Sep-16-25 04:59AM	New Strong Sell Stocks for September 16th (Zacks)
Sep-15-25 09:00AM	Assertio Presents First-Ever Real-World Study Showing Patient Experience with SYMPAZAN (clobazam) Oral Film, CIV (GlobeNewswire)
Sep-10-25 07:30AM	Assertio to Present New Data from Real-World Evidence Study of SYMPAZAN at upcoming 150th Annual Meeting of the American Neurological Association (GlobeNewswire)
Sep-03-25 08:15AM	Assertio to Participate in the HC Wainwright and Lake Street Conferences in September 2025 (GlobeNewswire)
Aug-26-25 06:17AM	New Strong Sell Stocks for August 26th (Zacks)
Aug-12-25 03:06AM	Assertio Holdings Inc (ASRT) Q2 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com) +13.85%
Aug-11-25 06:55PM	Assertio (ASRT) Reports Q2 Loss, Beats Revenue Estimates (Zacks)
05:54PM	Assertio: Q2 Earnings Snapshot (Associated Press Finance)
04:05PM	Assertio Reports Second Quarter 2025 Financial Results (GlobeNewswire)
Aug-08-25 09:31AM	Assertio Holdings Inc (ASRT) Q2 2025: Everything You Need To Know Ahead Of Earnings (GuruFocus.com)
Aug-06-25 03:41PM	Berger Montague PC Investigating Claims on Behalf of Spectrum Pharmaceuticals, Inc. (NASDAQ: SPPI) Investors (PR Newswire)
08:30AM	NewAmsterdam Pharma Company N.V. (NAMS) Reports Q2 Loss, Tops Revenue Estimates (Zacks)
Aug-05-25 08:30AM	Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025 (GlobeNewswire)
Jul-08-25 06:28AM	New Strong Sell Stocks for July 8th (Zacks)
Jun-30-25 06:03AM	New Strong Sell Stocks for June 30th (Zacks)
Jun-25-25 06:26AM	New Strong Sell Stocks for June 25th (Zacks)
Jun-18-25 05:08AM	New Strong Sell Stocks for June 18th (Zacks)
May-19-25 04:10PM	Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025 (GlobeNewswire) +6.77%
May-13-25 05:38AM	Q1 2025 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:09AM	Assertio Holdings Inc (ASRT) Q1 2025 Earnings Call Highlights: Navigating Challenges with ... (GuruFocus.com)
May-12-25 05:15PM	Assertio (ASRT) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:20PM	Assertio: Q1 Earnings Snapshot (Associated Press Finance)
04:01PM	Assertio Reports First Quarter 2025 Financial Results (GlobeNewswire)
May-09-25 09:48AM	Assertio Holdings Inc (ASRT) Q1 2025 Earnings Report Preview: What to Expect (GuruFocus.com)
May-08-25 05:40PM	OmniAb, Inc. (OABI) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
May-05-25 08:15AM	Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025 (GlobeNewswire) -6.46%
Apr-07-25 09:17AM	Journey Medical (DERM) Surges 9.1%: Is This an Indication of Further Gains? (Zacks) -6.19%
Mar-21-25 09:00AM	iAccess Alpha's Virtual Best Ideas Spring Investment Conference March 25-26, 2025 (ACCESSWIRE)
Mar-20-25 09:10AM	Assertio to Participate in the iAccess Alpha Virtual Best Ideas Conference on March 25-26, 2025 (GlobeNewswire)
Mar-13-25 12:58PM	Q4 2024 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -7.46%
03:08AM	Assertio Holdings Inc (ASRT) Q4 2024 Earnings Call Highlights: Strategic Growth Amidst Challenges (GuruFocus.com)
Mar-12-25 04:30PM	Assertio: Q4 Earnings Snapshot (Associated Press Finance)
04:05PM	Assertio Reports Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Mar-05-25 04:05PM	Assertio Holdings, Inc. to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 (GlobeNewswire) +6.49%
Jan-03-25 04:30PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Dec-17-24 08:30AM	Assertio Holdings, Inc. Appoints Mark Reisenauer to Its Board of Directors (GlobeNewswire)
Dec-13-24 08:00AM	Assertio Announces Results of Rolvedon (eflapegrastim-xnst) injection Same-Day Dosing Clinical Study (GlobeNewswire)
Dec-12-24 08:00AM	Assertio Holdings, Inc. Appoints Paul Schwichtenberg to New CTO Role, Mary Pietryga as CCO (GlobeNewswire)
Dec-06-24 07:00AM	Beam Therapeutics Announces Appointment of Sravan Emany as Chief Financial Officer (GlobeNewswire)
Nov-15-24 09:00AM	Buxton Helmsley Calls for Senate Hearing on Well-Documented Evident Clinical Data Fraud at Assertio (Business Wire)
Nov-12-24 09:41AM	Q3 2024 Assertio Holdings Inc Earnings Call (Thomson Reuters StreetEvents) -7.89%
Nov-11-24 04:09PM	Assertio: Q3 Earnings Snapshot (Associated Press Finance) +8.82%
04:02PM	Assertio Reports Third Quarter 2024 Financial Results (GlobeNewswire)
03:41PM	Buxton Helmsley Releases Evidence of Product-Related Fraud at Assertio (Business Wire)
07:30AM	Assertio Provides Response to Letter from Short-seller (GlobeNewswire)
Nov-08-24 09:00AM	Buxton Helmsley Issues Letter to Assertio Stockholders Disclosing Inversion to Short Position Following Board Refusal to Address Product-Related Fraud (Business Wire) -15.84%
07:06AM	Assertio Holdings Inc (ASRT) Q3 2024: Everything You Need to Know Ahead of Earnings (GuruFocus.com)
Oct-30-24 08:00AM	Assertio Holdings, Inc. to Report Third Quarter 2024 Financial Results on November 11, 2024 (GlobeNewswire)
Oct-11-24 08:00AM	Assertio to Participate in the Maxim Group Healthcare Virtual Summit on October 15, 2024 (GlobeNewswire)
Oct-09-24 05:18PM	Assertio Holdings Inc (ASRT) Q2 2024 Earnings Call Highlights: Navigating Sales Challenges and ... (GuruFocus.com)
Oct-04-24 04:05PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire)
Sep-03-24 04:05PM	Assertio to Participate in the HC Wainwright and Lake Street Conferences in New York City September 10-12, 2024 (GlobeNewswire) -5.93% +10.81%
Aug-07-24 04:47PM	Assertio: Q2 Earnings Snapshot (Associated Press Finance) -11.79%
04:01PM	Assertio Reports Second Quarter 2024 Financial Results (GlobeNewswire)
Jul-24-24 04:05PM	Assertio Holdings, Inc. to Report Second Quarter 2024 Financial Results on August 7, 2024 (GlobeNewswire) -6.17%
09:00AM	Buxton Helmsley Issues Letter to the Board of Directors of Assertio Holdings, Inc. (Business Wire)
Jul-09-24 04:30PM	Assertio Holdings, Inc. Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (GlobeNewswire) +8.11%

Assertio Holdings, Inc. is a commercial pharmaceutical company, which engages in acquisitions, licensing, and mergers. The firm focuses on portfolio of neurology, inflammation, and pain medications. Its products include INDOCIN, Sympazan, Otrexup, SPRIX, CAMBIA, and Zipsor. The company was founded on August 7, 1995 and is headquartered in Lake Forest, IL.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Schlessinger Sam	EVP, General Counsel	Feb 21 '26	Option Exercise	0.00	1,143	0	15,248	Feb 24 06:02 PM
Patel Ajay	EVP and CFO	Feb 21 '26	Option Exercise	0.00	1,143	0	16,508	Feb 24 06:01 PM
Schwichtenberg Paul	President and COO	Feb 21 '26	Option Exercise	0.00	1,143	0	14,553	Feb 24 06:01 PM
Schlessinger Sam	EVP, General Counsel	Feb 18 '26	Option Exercise	0.00	2,778	0	15,344	Feb 20 06:01 PM
Schwichtenberg Paul	President and COO	Feb 18 '26	Option Exercise	0.00	2,778	0	14,787	Feb 20 06:00 PM
Patel Ajay	EVP and CFO	Feb 18 '26	Option Exercise	0.00	2,778	0	16,742	Feb 20 06:00 PM
Schlessinger Sam	EVP, General Counsel	Feb 07 '26	Option Exercise	0.00	1,389	0	13,185	Feb 10 06:27 PM
Schwichtenberg Paul	President and COO	Feb 07 '26	Option Exercise	0.00	1,666	0	12,834	Feb 10 06:27 PM
Patel Ajay	EVP and CFO	Feb 07 '26	Option Exercise	0.00	1,666	0	14,789	Feb 10 06:26 PM
Stark David Matthew	Director	Nov 10 '25	Sale	0.76	8,959	6,806	98,541	Nov 12 06:00 PM
DAVID STARK	Director	Nov 10 '25	Proposed Sale	0.76	8,959	6,806		Nov 10 04:07 PM
O'Grady Brendan P.	CEO	May 31 '25	Option Exercise	0.00	166,665	0	178,371	Jun 03 06:00 PM
Schlessinger Sam	EVP, General Counsel	May 12 '25	Option Exercise	0.00	38,017	0	191,906	May 14 06:03 PM
Schwichtenberg Paul	See Remarks	May 12 '25	Option Exercise	0.00	38,017	0	184,362	May 14 06:01 PM
Patel Ajay	EVP and CFO	May 12 '25	Option Exercise	0.00	38,017	0	213,692	May 14 06:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ASRT

Assertio Holdings Inc

Upgrade your FINVIZ experience